[8-K] Jakks Pacific Inc Reports Material Event
On 24 Jul 2025 AEye, Inc. (Nasdaq: LIDR) filed Amendment No. 3 to its 424(b)(5) prospectus supplements for its Form S-3 at-the-market (ATM) equity program with A.G.P./Alliance Global Partners. The amendment raises the maximum aggregate offering price that may be sold under the Sales Agreement from $2.6 million to $23.728 million, equal to one-third of the company鈥檚 $71.2 million public float, as permitted by General Instruction I.B.6.
AEye has already issued $14.993 million of securities under this rule in the last 12-month period; combined future sales cannot surpass the updated $23.728 million cap unless a further supplement is filed. Key metrics disclosed: 25.42 million shares outstanding, of which 24.38 million are held by non-affiliates; last reported share price $2.92. The company continues to qualify as an 鈥渆merging growth鈥� and 鈥渟maller reporting鈥� company, benefiting from reduced reporting requirements. Investors are directed to previously disclosed risk factors for additional considerations.
Il 24 luglio 2025, AEye, Inc. (Nasdaq: LIDR) ha presentato la Terza Modifica ai supplementi al prospetto 424(b)(5) relativi al suo programma azionario at-the-market (ATM) tramite il modulo S-3, in collaborazione con A.G.P./Alliance Global Partners. La modifica aumenta il prezzo massimo aggregato di offerta vendibile ai sensi dell'Accordo di Vendita da 2,6 milioni di dollari a 23,728 milioni di dollari, pari a un terzo del flottante pubblico della societ脿 di 71,2 milioni di dollari, come consentito dall'Istruzione Generale I.B.6.
AEye ha gi脿 emesso titoli per un valore di 14,993 milioni di dollari nell'ultimo periodo di 12 mesi secondo questa norma; le vendite future combinate non possono superare il nuovo limite di 23,728 milioni di dollari a meno che non venga presentato un ulteriore supplemento. Metriche chiave comunicate: 25,42 milioni di azioni in circolazione, di cui 24,38 milioni detenute da non affiliati; ultimo prezzo riportato per azione 2,92 dollari. La societ脿 mantiene la qualifica di "emerging growth" e "smaller reporting" company, beneficiando di requisiti di reporting ridotti. Si invita gli investitori a consultare i fattori di rischio gi脿 divulgati per ulteriori informazioni.
El 24 de julio de 2025, AEye, Inc. (Nasdaq: LIDR) present贸 la Enmienda N潞 3 a sus suplementos del prospecto 424(b)(5) para su programa de acciones at-the-market (ATM) mediante el formulario S-3, con A.G.P./Alliance Global Partners. La enmienda eleva el precio m谩ximo agregado de oferta que puede venderse bajo el Acuerdo de Venta de 2,6 millones de d贸lares a 23,728 millones de d贸lares, equivalente a un tercio del float p煤blico de la compa帽铆a de 71,2 millones de d贸lares, seg煤n lo permitido por la Instrucci贸n General I.B.6.
AEye ya ha emitido valores por un total de 14,993 millones de d贸lares bajo esta regla en los 煤ltimos 12 meses; las ventas futuras combinadas no pueden superar el nuevo l铆mite de 23,728 millones de d贸lares a menos que se presente un suplemento adicional. M茅tricas clave divulgadas: 25,42 millones de acciones en circulaci贸n, de las cuales 24,38 millones son propiedad de no afiliados; 煤ltimo precio reportado por acci贸n 2,92 d贸lares. La compa帽铆a sigue calificando como "emerging growth" y "smaller reporting" company, benefici谩ndose de requisitos de reporte reducidos. Se recomienda a los inversores consultar los factores de riesgo previamente divulgados para m谩s detalles.
2025雲� 7鞗� 24鞚�, AEye, Inc. (雮橃姢雼�: LIDR)電� A.G.P./Alliance Global Partners鞕� 頃粯 Form S-3鞚� 424(b)(5) 歃濌秾 氚滍枆 氤挫订靹� 3彀� 靾橃爼鞎堨潉 鞝滌稖頄堨姷雼堧嫟. 鞚� 靾橃爼鞎堨潃 韺愲Г 瓿勳暯鞐� 霐半ジ 斓滊寑 齑� 氚滍枆 旮堨暋鞚� 260毵� 雼煬鞐愳劀 2,372.8毵� 雼煬搿� 靸來枼 臁办爼頄堨溂氅�, 鞚措姅 須岇偓鞚� 7,120毵� 雼煬 瓿奠 鞙犿喌 欤检嫕 臧�旃橃潣 3攵勳潣 1鞐� 頃措嫻頃橂┌, 鞚茧皹 歆�旃� I.B.6鞐� 霐半澕 項堨毄霅╇媹雼�.
AEye電� 歆�雮� 12臧滌洈 霃欖晥 鞚� 攴滌箼鞐� 霐半澕 鞚措 1,499.3毵� 雼煬 靸侂嫻鞚� 歃濌秾鞚� 氚滍枆頄堨溂氅�, 鞎烄溂搿滌潣 韺愲Г鞎§潃 於旉皜 氤挫订靹� 鞝滌稖 鞐嗢澊電� 靾橃爼霅� 2,372.8毵� 雼煬 頃滊弰毳� 齑堦臣頃� 靾� 鞐嗢姷雼堧嫟. 欤检殧 歆�響�: 2,542毵� 欤� 氚滍枆, 攴胳 2,438毵� 欤茧姅 牍勱硠鞐挫偓 氤挫湢; 斓滉芳 氤搓碃霅� 欤缄皜 2.92雼煬. 須岇偓電� 瓿勳啀頃挫劀 "emerging growth" 氚� "smaller reporting" 須岇偓搿� 攵勲霅橃柎 氤搓碃 鞖旉贝鞚� 鞕勴檾霅╇媹雼�. 韴瀽鞛愲摛鞚� 於旉皜 瓿犽牑靷暛鞚� 鞙勴暣 鞚挫爠鞐� 瓿店皽霅� 鞙勴棙 鞖旍唽毳� 彀戈碃頃橃嫓旮� 氚旊瀺雼堧嫟.
Le 24 juillet 2025, AEye, Inc. (Nasdaq : LIDR) a d茅pos茅 l'Amendement n掳3 脿 ses suppl茅ments de prospectus 424(b)(5) relatifs 脿 son programme d'actions en continu (ATM) via le formulaire S-3, en collaboration avec A.G.P./Alliance Global Partners. Cet amendement augmente le prix maximum global d'offre pouvant 锚tre vendu dans le cadre de l'accord de vente, passant de 2,6 millions de dollars 脿 23,728 millions de dollars, soit un tiers du flottant public de la soci茅t茅 茅valu茅 脿 71,2 millions de dollars, conform茅ment 脿 l'instruction g茅n茅rale I.B.6.
AEye a d茅j脿 茅mis pour 14,993 millions de dollars de titres selon cette r猫gle au cours des 12 derniers mois ; les ventes futures combin茅es ne peuvent d茅passer le nouveau plafond de 23,728 millions de dollars sans d茅p么t d'un suppl茅ment suppl茅mentaire. Principaux indicateurs communiqu茅s : 25,42 millions d'actions en circulation, dont 24,38 millions d茅tenues par des non-affili茅s ; dernier cours rapport茅 2,92 dollars. La soci茅t茅 continue de b茅n茅ficier du statut de 芦 emerging growth 禄 et de 芦 smaller reporting 禄 company, profitant ainsi d'exigences de reporting all茅g茅es. Les investisseurs sont invit茅s 脿 consulter les facteurs de risque pr茅c茅demment divulgu茅s pour plus d'informations.
Am 24. Juli 2025 reichte AEye, Inc. (Nasdaq: LIDR) die 脛nderung Nr. 3 zu seinen 424(b)(5)-Prospekterg盲nzungen f眉r sein Form S-3 At-the-Market (ATM) Aktienprogramm bei A.G.P./Alliance Global Partners ein. Die 脛nderung erh枚ht den maximalen Gesamtangebotswert, der gem盲脽 dem Verkaufsvertrag verkauft werden darf, von 2,6 Millionen US-Dollar auf 23,728 Millionen US-Dollar, was einem Drittel des 枚ffentlichen Streubesitzes des Unternehmens in H枚he von 71,2 Millionen US-Dollar entspricht, wie in der Allgemeinen Anweisung I.B.6 erlaubt.
AEye hat im letzten 12-Monats-Zeitraum bereits Wertpapiere im Wert von 14,993 Millionen US-Dollar nach dieser Regelung ausgegeben; zuk眉nftige kombinierte Verk盲ufe d眉rfen die aktualisierte Grenze von 23,728 Millionen US-Dollar nicht 眉berschreiten, es sei denn, es wird eine weitere Erg盲nzung eingereicht. Wichtige Kennzahlen: 25,42 Millionen ausstehende Aktien, davon 24,38 Millionen im Besitz von Nicht-Affiliates; letzter gemeldeter Aktienkurs 2,92 US-Dollar. Das Unternehmen qualifiziert sich weiterhin als 鈥瀍merging growth鈥� und 鈥瀞maller reporting鈥� Unternehmen und profitiert von reduzierten Berichtspflichten. Investoren wird empfohlen, die zuvor offengelegten Risikofaktoren f眉r weitere Informationen zu beachten.
- Increased capital flexibility: authority to sell up to $23.728 M of common stock provides a readily accessible funding source.
- Regulatory compliance affirmed: filing demonstrates adherence to Form S-3 I.B.6 limits and ongoing Nasdaq listing.
- Dilution risk: issuance of additional stock鈥攗p to one-third of public float鈥攃ould dilute existing shareholders.
- Significant prior sales: $14.993 M already sold in last 12 months means only about $8.7 M capacity remains before a new supplement is needed.
Insights
TL;DR: Amendment ups ATM capacity to $23.7 M, improving liquidity but adding dilution risk; overall impact is neutral.
The filing expands AEye鈥檚 at-the-market shelf capacity to one-third of public float, giving management flexibility to raise up to $8.7 M more before reaching the 12-month cap (after $15 M already sold). Additional cash could support operations without a traditional follow-on offering, but incremental issuance at roughly $3/share may materially dilute existing holders. No use-of-proceeds update or financial guidance is provided, limiting visibility on capital needs. Because the amendment simply adjusts the ceiling within regulatory limits and does not mandate immediate issuance, I view the disclosure as neutral for valuation in the near term.
Il 24 luglio 2025, AEye, Inc. (Nasdaq: LIDR) ha presentato la Terza Modifica ai supplementi al prospetto 424(b)(5) relativi al suo programma azionario at-the-market (ATM) tramite il modulo S-3, in collaborazione con A.G.P./Alliance Global Partners. La modifica aumenta il prezzo massimo aggregato di offerta vendibile ai sensi dell'Accordo di Vendita da 2,6 milioni di dollari a 23,728 milioni di dollari, pari a un terzo del flottante pubblico della societ脿 di 71,2 milioni di dollari, come consentito dall'Istruzione Generale I.B.6.
AEye ha gi脿 emesso titoli per un valore di 14,993 milioni di dollari nell'ultimo periodo di 12 mesi secondo questa norma; le vendite future combinate non possono superare il nuovo limite di 23,728 milioni di dollari a meno che non venga presentato un ulteriore supplemento. Metriche chiave comunicate: 25,42 milioni di azioni in circolazione, di cui 24,38 milioni detenute da non affiliati; ultimo prezzo riportato per azione 2,92 dollari. La societ脿 mantiene la qualifica di "emerging growth" e "smaller reporting" company, beneficiando di requisiti di reporting ridotti. Si invita gli investitori a consultare i fattori di rischio gi脿 divulgati per ulteriori informazioni.
El 24 de julio de 2025, AEye, Inc. (Nasdaq: LIDR) present贸 la Enmienda N潞 3 a sus suplementos del prospecto 424(b)(5) para su programa de acciones at-the-market (ATM) mediante el formulario S-3, con A.G.P./Alliance Global Partners. La enmienda eleva el precio m谩ximo agregado de oferta que puede venderse bajo el Acuerdo de Venta de 2,6 millones de d贸lares a 23,728 millones de d贸lares, equivalente a un tercio del float p煤blico de la compa帽铆a de 71,2 millones de d贸lares, seg煤n lo permitido por la Instrucci贸n General I.B.6.
AEye ya ha emitido valores por un total de 14,993 millones de d贸lares bajo esta regla en los 煤ltimos 12 meses; las ventas futuras combinadas no pueden superar el nuevo l铆mite de 23,728 millones de d贸lares a menos que se presente un suplemento adicional. M茅tricas clave divulgadas: 25,42 millones de acciones en circulaci贸n, de las cuales 24,38 millones son propiedad de no afiliados; 煤ltimo precio reportado por acci贸n 2,92 d贸lares. La compa帽铆a sigue calificando como "emerging growth" y "smaller reporting" company, benefici谩ndose de requisitos de reporte reducidos. Se recomienda a los inversores consultar los factores de riesgo previamente divulgados para m谩s detalles.
2025雲� 7鞗� 24鞚�, AEye, Inc. (雮橃姢雼�: LIDR)電� A.G.P./Alliance Global Partners鞕� 頃粯 Form S-3鞚� 424(b)(5) 歃濌秾 氚滍枆 氤挫订靹� 3彀� 靾橃爼鞎堨潉 鞝滌稖頄堨姷雼堧嫟. 鞚� 靾橃爼鞎堨潃 韺愲Г 瓿勳暯鞐� 霐半ジ 斓滊寑 齑� 氚滍枆 旮堨暋鞚� 260毵� 雼煬鞐愳劀 2,372.8毵� 雼煬搿� 靸來枼 臁办爼頄堨溂氅�, 鞚措姅 須岇偓鞚� 7,120毵� 雼煬 瓿奠 鞙犿喌 欤检嫕 臧�旃橃潣 3攵勳潣 1鞐� 頃措嫻頃橂┌, 鞚茧皹 歆�旃� I.B.6鞐� 霐半澕 項堨毄霅╇媹雼�.
AEye電� 歆�雮� 12臧滌洈 霃欖晥 鞚� 攴滌箼鞐� 霐半澕 鞚措 1,499.3毵� 雼煬 靸侂嫻鞚� 歃濌秾鞚� 氚滍枆頄堨溂氅�, 鞎烄溂搿滌潣 韺愲Г鞎§潃 於旉皜 氤挫订靹� 鞝滌稖 鞐嗢澊電� 靾橃爼霅� 2,372.8毵� 雼煬 頃滊弰毳� 齑堦臣頃� 靾� 鞐嗢姷雼堧嫟. 欤检殧 歆�響�: 2,542毵� 欤� 氚滍枆, 攴胳 2,438毵� 欤茧姅 牍勱硠鞐挫偓 氤挫湢; 斓滉芳 氤搓碃霅� 欤缄皜 2.92雼煬. 須岇偓電� 瓿勳啀頃挫劀 "emerging growth" 氚� "smaller reporting" 須岇偓搿� 攵勲霅橃柎 氤搓碃 鞖旉贝鞚� 鞕勴檾霅╇媹雼�. 韴瀽鞛愲摛鞚� 於旉皜 瓿犽牑靷暛鞚� 鞙勴暣 鞚挫爠鞐� 瓿店皽霅� 鞙勴棙 鞖旍唽毳� 彀戈碃頃橃嫓旮� 氚旊瀺雼堧嫟.
Le 24 juillet 2025, AEye, Inc. (Nasdaq : LIDR) a d茅pos茅 l'Amendement n掳3 脿 ses suppl茅ments de prospectus 424(b)(5) relatifs 脿 son programme d'actions en continu (ATM) via le formulaire S-3, en collaboration avec A.G.P./Alliance Global Partners. Cet amendement augmente le prix maximum global d'offre pouvant 锚tre vendu dans le cadre de l'accord de vente, passant de 2,6 millions de dollars 脿 23,728 millions de dollars, soit un tiers du flottant public de la soci茅t茅 茅valu茅 脿 71,2 millions de dollars, conform茅ment 脿 l'instruction g茅n茅rale I.B.6.
AEye a d茅j脿 茅mis pour 14,993 millions de dollars de titres selon cette r猫gle au cours des 12 derniers mois ; les ventes futures combin茅es ne peuvent d茅passer le nouveau plafond de 23,728 millions de dollars sans d茅p么t d'un suppl茅ment suppl茅mentaire. Principaux indicateurs communiqu茅s : 25,42 millions d'actions en circulation, dont 24,38 millions d茅tenues par des non-affili茅s ; dernier cours rapport茅 2,92 dollars. La soci茅t茅 continue de b茅n茅ficier du statut de 芦 emerging growth 禄 et de 芦 smaller reporting 禄 company, profitant ainsi d'exigences de reporting all茅g茅es. Les investisseurs sont invit茅s 脿 consulter les facteurs de risque pr茅c茅demment divulgu茅s pour plus d'informations.
Am 24. Juli 2025 reichte AEye, Inc. (Nasdaq: LIDR) die 脛nderung Nr. 3 zu seinen 424(b)(5)-Prospekterg盲nzungen f眉r sein Form S-3 At-the-Market (ATM) Aktienprogramm bei A.G.P./Alliance Global Partners ein. Die 脛nderung erh枚ht den maximalen Gesamtangebotswert, der gem盲脽 dem Verkaufsvertrag verkauft werden darf, von 2,6 Millionen US-Dollar auf 23,728 Millionen US-Dollar, was einem Drittel des 枚ffentlichen Streubesitzes des Unternehmens in H枚he von 71,2 Millionen US-Dollar entspricht, wie in der Allgemeinen Anweisung I.B.6 erlaubt.
AEye hat im letzten 12-Monats-Zeitraum bereits Wertpapiere im Wert von 14,993 Millionen US-Dollar nach dieser Regelung ausgegeben; zuk眉nftige kombinierte Verk盲ufe d眉rfen die aktualisierte Grenze von 23,728 Millionen US-Dollar nicht 眉berschreiten, es sei denn, es wird eine weitere Erg盲nzung eingereicht. Wichtige Kennzahlen: 25,42 Millionen ausstehende Aktien, davon 24,38 Millionen im Besitz von Nicht-Affiliates; letzter gemeldeter Aktienkurs 2,92 US-Dollar. Das Unternehmen qualifiziert sich weiterhin als 鈥瀍merging growth鈥� und 鈥瀞maller reporting鈥� Unternehmen und profitiert von reduzierten Berichtspflichten. Investoren wird empfohlen, die zuvor offengelegten Risikofaktoren f眉r weitere Informationen zu beachten.
FAQ
How much stock can AEye (LIDR) now sell under its ATM program?
How much has AEye already raised via the ATM in the past 12 months?
What is AEye鈥檚 current public float and share price?
Will the amendment immediately dilute existing shareholders?
Why did AEye file Amendment No. 3 to its prospectus supplements?
